Cancer cells eat their neighbors' 'words'

March 7, 2016, Rice University
Rice University researchers found that some cancer cells get as much as 60 percent of their fuel from eating exosomes, tiny communications packets emitted by neighboring cells. The team includes (from left) Lifeng Yang, Deepak Nagrath, Joelle Baddour, Abhinav Achreja and Hongyun Zhao. Credit: Tommy LaVergne/Rice University

Cancer cells are well-known as voracious energy consumers, but even veteran cancer-metabolism researcher Deepak Nagrath was surprised by their latest exploit: Experiments in his lab at Rice University show that some cancer cells get 30-60 percent of their fuel from eating their neighbors' "words."

"Our original hypothesis was that cancer cells were modifying their metabolism based on communications they were receiving from cells in the microenvironment near the tumor," said Nagrath, assistant professor of chemical and biomolecular engineering at Rice and co-author of a new study describing the research in the open-access journal eLife. "None of us expected to find that they were converting the signals directly into energy."

The results were part of a four-year study by Nagrath, his students and collaborators at the University of Texas MD Anderson Cancer Center and other institutions about the role of exosomes in cancer metabolism. Exosomes are tiny packets of proteins, microRNA and nucleic acids that cells emit into their environment to both communicate with neighboring cells and influence their behavior. Nagrath, who directs Rice's Laboratory for Systems Biology of Human Diseases, found that some cancer cells are capable of using these information packets as a source of energy to fuel tumor growth.

Nagrath's team specializes in analyzing the unique metabolic profiles of various types of cancer.

His work is the latest in a series of discoveries about cancer metabolism that date to German chemist Otto Warburg's 1924 discovery that cancer cells produce far more energy from the metabolic process known as glycolysis than do . The Nobel Prize-winning discovery of the "Warburg effect" led scientists to believe, for decades, that all cancers were dependent on glycolysis. Nagrath's lab and others have shown in recent years that the truth is far more complex: Each type of cancer has a unique metabolic profile. Nagrath's work aims at better understanding those profiles and their role in cancer metastasis and drug resistance, and he ultimately hopes to use the knowledge to develop more effective cancer treatments.

In a May 2014 study, Nagrath and colleagues found that highly aggressive ovarian cancer cells were glutamine-dependent and that depriving the cells of external sources of glutamine—as some experimental drugs do—was an effective way to kill late-stage in the lab. And a December 2014 study found that ovarian tumors coax into providing key metabolites they need to grow.

The exosome study began four years ago based upon a growing realization that exosomes might play a role in regulating .

"A growing body of evidence suggests that exosomes can facilitate crosstalk between cancer cells and other types of cells that are nearby in the microenvironment that surrounds the tumor," said Hongyun Zhao, the first author of the eLife study. "Some studies suggested that exosomes harbored the potential to regulate cancer cell metabolism, but most research had focused on the exosomes that were produced and emitted by cancer cells themselves. We decided to look at the exosomes of , a type of cell that is commonly found in the tumor microenvironment, and see if stromal exosomes were influencing the energy consumption of cancer cells."

Zhao's first experiments involved growing cultures of stromal cells, extracting their exosomes and exposing them to cancer cells, which were then monitored for metabolic changes. Nagrath said the tests suggested that the cancer was fueling itself by consuming amino acids directly from the exosomes, and a series of monthslong follow-up tests had to be conducted to rule out other possibilities.

"Our results show that not only do exosomes enhance the phenomenon of the 'Warburg effect' in tumors, but exosomes also contain 'off-the-shelf' metabolites within their cargo that cancer cells use directly in their metabolic processes," Zhao said.

Nagrath said some of Zhao's follow-up tests also suggest possible new treatment regimes. For example, in some tests, Zhao exposed cancer cell cultures to drugs that were known to block the uptake of exosomal signals. The tests, which showed that the cancer cell's metabolic activity dropped significantly, helped prove that the tumors were using the exosomes as fuel. The fact that four of the drugs used in the tests—heparin, cytochalasin D, ethyl-isopropyl amiloride and choloroquine—are already approved by the Food and Drug Administration for other uses suggests that they may also be useful as chemotherapeutic agents, Nagrath said.

"Disruption of the exosomal metabolic adaptation of could provide a novel therapeutic avenue for exploitation," he said.

Explore further: Cancer uses abdominal stem cells to fuel growth and metastasis

More information: Hongyun Zhao et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism, eLife (2016). DOI: 10.7554/eLife.10250

Related Stories

Cancer uses abdominal stem cells to fuel growth and metastasis

December 3, 2014
(Medical Xpress)—New research from Rice University and the University of Texas MD Anderson Cancer Center shows how ovarian tumors co-opt a specific type of adult stem cell from abdominal tissues to fuel their growth. The ...

Glutamine ratio is key ovarian cancer indicator

May 5, 2014
A Rice University-led analysis of the metabolic profiles of hundreds of ovarian tumors has revealed a new test to determine whether ovarian cancer cells have the potential to metastasize, or spread to other parts of the body. ...

How the breast cancer cells transform normal cells into tumoral ones?

November 13, 2014
Researchers at the Bellvitge Biomedical Research Institute of Bellvitge, the Catalan Institute of Oncology and the University Hospital of Bellvitge have participated in an international study published in the journal Cancer ...

Study could lead to 'liquid biopsy' tests for bladder cancer

January 22, 2014
Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.

Cancer exosome 'micro factories' aid in cancer progression

October 23, 2014
Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University ...

Researchers kill drug-resistant lung cancer with 50 times less chemo

January 14, 2016
The cancer drug paclitaxel just got more effective. For the first time, researchers from the University of North Carolina at Chapel Hill have packaged it in containers derived from a patient's own immune system, protecting ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.